1. Home
  2. VRAX vs OFAL Comparison

VRAX vs OFAL Comparison

Compare VRAX & OFAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$2.85

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Logo OFA Group Ordinary Shares

OFAL

OFA Group Ordinary Shares

N/A

Current Price

$0.64

Market Cap

1.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
VRAX
OFAL
Founded
2013
2013
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Military/Government/Technical
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
1.7M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
VRAX
OFAL
Price
$2.85
$0.64
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
481.2K
6.8M
Earning Date
06-12-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$716,885.00
Revenue This Year
$217,274.83
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
254.88
52 Week Low
$0.10
$0.08
52 Week High
$13.19
$3.79

Technical Indicators

Market Signals
Indicator
VRAX
OFAL
Relative Strength Index (RSI) 50.61 45.63
Support Level $2.55 $0.52
Resistance Level $3.10 $0.72
Average True Range (ATR) 0.19 0.11
MACD -0.02 -0.04
Stochastic Oscillator 30.61 4.83

Price Performance

Historical Comparison
VRAX
OFAL

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

About OFAL OFA Group Ordinary Shares

OFA Group provides interior design, fit-out, project management and application services in Hong Kong for commercial and residential buildings. Its interior design services include consultation, conceptualized designs, layout plans, detailed design drawings and advice on budgetary considerations, space utilization, materials, fittings, furniture, appliances and other items. Its fit-out services include the installation of protective materials, partition walls, windows, decorative fittings, furniture, fixtures, plumbing systems, switches, power outlets, telephone wiring, computer outlet covers and other electrical and wiring works. The Group is transitioning from a project-based model to a subscription-based model for AI tools, real estate development and senior care infrastructure.

Share on Social Networks: